Concepedia

Thierry Masquelin

TM

Statistics

Publications

36

Citations

1.7K

H-Index

27

Active since

1994

Affiliations

Eli Lilly (United States)(Current)

Roche (Switzerland)

Infectious Disease Research Institute

Cornell University

University of Dundee

Thierry Masquelin is an author at Eli Lilly (United States) specializing in medicinal chemistry, drug discovery, and pharmacy.

Publications per year

1994–2021

36

Publications

36

Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development

Tiago Beites, Kathryn O’Brien, Divya Tiwari et al. · Nature Communications · 2019 · 147 citations · Full text

, , +15

Prediction of Drug Penetration in Tuberculosis Lesions

Jansy P. Sarathy, Fabio Zuccotto, Hsinpin Ho et al. · ACS Infectious Diseases · 2016 · 145 citations · Full text

, , +17

A remote-controlled adaptive medchem lab: an innovative approach to enable drug discovery in the 21st Century

Alexander G. Godfrey, Thierry Masquelin, Horst Hemmerle · Drug Discovery Today · 2013 · 129 citations

, , +8

Sequential Ugi/Strecker reactions via microwave assisted organic synthesis: novel 3-center-4-component and 3-center-5-component multi-component reactions

Thierry Masquelin, Hai H. Bui, Bob Brickley et al. · Tetrahedron Letters · 2006 · 80 citations

, , +13

New multi-component reaction accessing 3-aminoimidazo[1,2-a]pyridines

John Schwerkoske, Thierry Masquelin, Tom Perun et al. · Tetrahedron Letters · 2005 · 72 citations

, , +11

1–5 of 36